Mgc Pharmaceuticals Limited

-0.03 (-7.79%)

Mgc Pharmaceuticals Financial Summary

The current MXC market cap is 9.69M. The company's latest EPS is -0.7 and P/E is N/A.

Year End 30 June 20182019202020212022
Total Revenue 316k988k2.75M3.85M4.74M
Operating Income -8.93M-10.72M-17M-11.8M-19.4M
Net Income -8.25M-8.58M-19.36M-15.87M-20.35M
Year End 30 June 20182019202020212022
Total Assets 19.99M13M7.93M24.24M18.56M
Total Liabilities 7.3M2.2M4.84M10.41M13.38M
Total Equity 12.69M10.8M3.09M13.83M5.18M
Year End 30 June 20182019202020212022
Operating -5.89M-6.35M-9.96M-11.99M-12.16M
Investing -340k-947k-970k-1.49M-1.11M
Financing 4.7M27k10.46M17.05M9.74M
Market Cap 9.69M
Price to Earnings Ratio N/A
Price to Sales Ratio
Price to Cash Ratio
Price to Book Ratio
Dividend Yield -

Share Statistics

Shares Outstanding 2.73B
Average Volume (1 week) 4.8M
Average Volume (1 Month) 2.41M
52 Week Change -69.13%
52 Week High 1.55
52 Week Low 0.355
Spread (Intraday) 0.01 (2.78%)

Company Info

Company Name Mgc Pharmaceuticals Limited
Address 1202 hay street
perth, western australia 6005
Industry drug & proprietary stores (5912)
Your Recent History
Mgc Pharma..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |

V: D: 20230607 22:43:43